Image de couverture de livre

Exercise and diet effects on delay discounting and related neurobiology in adults with overweight or obesity: A randomized trial

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Kelly T. Cosgrove, Marc‐Andre Cornier, Maureen McHugo, Edward L. Melanson, Allison Hild, Eugene Kronberg, Elizabeth A. Thomas, Keith Dodd, Eric D. Claus, Jason R. Tregellas, Kristina T. Legget
Format:	Artículo Open Access
Publié:	Wiley 2025
Sujets:	Obesity
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Impact of Obesity on Appetite‐Related Behaviors and Biomarkers in Older Adults: A Cross‐Sectional Study
par: Sean J. Iwamoto, et autres
Publié: (2025)

β‐alanine supplementation in adults with overweight and obesity: a randomized controlled feasibility trial
par: Joseph J. Matthews, et autres
Publié: (2025)

Musculoskeletal characteristics in older adults with overweight or obesity: INVEST in Bone Health trial baseline analysis
par: S. Delanie Lynch, et autres
Publié: (2025)

Digitally enhanced ketogenic diet versus low‐fat diet for cardio‐renal‐metabolic health in a predominantly Hispanic adult population with overweight or obesity: Pilot randomised clinical trial
par: Yan Du, et autres
Publié: (2025)

Improved health‐related quality of life with tirzepatide versus semaglutide in adults with obesity or overweight from the SURMOUNT ‐5 trial
par: Alpana P. Shukla, et autres
Publié: (2025)

Association of overweight/obesity and overweight/obesity‐related metabolic dysfunction‐associated steatotic liver disease in young adults with coronary artery calcification later in life
par: Jia‐Jie Wang, et autres
Publié: (2024)

Exploring the perceptions of Chinese adults toward overweight and obesity: A systematic literature review
par: Yixi Wang‐Chen, et autres
Publié: (2025)

Efficacy and safety of intragastric expandable oral capsules in adults with overweight or obesity: A randomized, double‐blind, placebo‐controlled trial
par: Difei Lu, et autres
Publié: (2024)

Tirzepatide and health‐related quality of life in adults with obesity or overweight: Results from the SURMOUNT ‐3 phase 3 randomized trial
par: Theresa Hunter Gibble, et autres
Publié: (2025)

Efficacy and safety of a novel oral hydrogel capsule in adults with overweight or obesity: the pivotal randomized RESET study
par: Jamy D. Ard, et autres
Publié: (2025)

Gastrointestinal tolerability and weight reduction associated with tirzepatide in adults with obesity or overweight with and without type 2 diabetes in the SURMOUNT ‐1 to ‐4 trials
par: Domenica M. Rubino, et autres
Publié: (2025)

Effects of light‐intensity physical activity on cardiometabolic parameters in young adults with overweight and obesity: The SED ‐ ACT randomized controlled crossover trial
par: Sascha W. Hoffmann, et autres
Publié: (2024)

Clinical practice guidelines for the management of overweight and obesity published internationally: A scoping review
par: Cadeyrn J. Gaskin, et autres
Publié: (2024)

Impact of lifestyle moderate‐to‐vigorous physical activity timing on glycemic control in sedentary adults with overweight/obesity and metabolic impairments
par: Antonio Clavero‐Jimeno, et autres
Publié: (2024)

Exploring potential reach and representativeness of a self‐weighing weight gain prevention intervention in adults with overweight and obesity
par: Kellie B. Scotti, et autres
Publié: (2024)

Greater Increase in Hippocampal Activity During the Early Postnatal Period After Preterm Birth Is Associated With Better Cognitive and Motor Outcomes at 18 Months
par: Anika Guha, et autres
Publié: (2025)

Body composition changes during weight reduction with tirzepatide in the SURMOUNT ‐1 study of adults with obesity or overweight
par: Michelle Look, et autres
Publié: (2025)

Myocardial mechano‐energetic efficiency is not impaired in patients with metabolically healthy overweight and obesity
par: Chiara Maria Assunta Cefalo, et autres
Publié: (2024)

Maternal folic acid supplementation during pregnancy in association with childhood overweight or obesity
par: Chi‐Yen Hung, et autres
Publié: (2024)

Impact of weight on daily activities questionnaire in patients with overweight or obesity: Psychometric evaluation using data from the OASIS 1 trial
par: Lisa von Huth Smith, et autres
Publié: (2025)

Potential pathways to the onset and development of eating disorders in people with overweight and obesity: A scoping review
par: Rabia Khalid, et autres
Publié: (2024)

Efsubaglutide alfa in adults with overweight or obesity: Protocol for a seamless, adaptive phase 2b/3 randomized, double‐blind, placebo‐controlled trial ( LIGHT 2)
par: Weiping Jia, et autres
Publié: (2026)

Association between patient‐reported eating behaviours and weight change: Secondary analyses of a randomized, double‐blind trial comparing retatrutide and placebo in people with obesity or overweight
par: Chisom Kanu, et autres
Publié: (2025)

The impact of behavioral weight management interventions on eating behavior traits in adults with overweight or obesity: A systematic review and meta‐analysis
par: Laura Kudlek, et autres
Publié: (2024)

Correction to “Body composition changes during weight reduction with tirzepatide in the SURMOUNT ‐1 study of adults with obesity or overweight”
Publié: (2025)

Modeling potential cost‐effectiveness of tirzepatide versus lifestyle modification for patients with overweight and obesity
par: Meredith M. Hoog, et autres
Publié: (2025)

Longer‐term effects of intermittent fasting on body composition and cardiometabolic health in adults with overweight and obesity: A systematic review and meta‐analysis
par: Mousa Khalafi, et autres
Publié: (2024)

Development and validation of an eating behavior patient‐reported outcome measure in people living with obesity or overweight
par: Donald M. Bushnell, et autres
Publié: (2025)

Involvement of the FTO A > T polymorphism in body composition and lipid profile changes after aerobic training in adults with overweight and obesity
par: Herik Fonseca, et autres
Publié: (2026)

Efficacy of an mHealth‐delivered behavioral intervention on weight loss and cardiometabolic risk in African American postpartum people with overweight or obesity: the SnapBack randomized controlled trial
par: Sharon J. Herring, et autres
Publié: (2024)

Effect of semaglutide 2.4 mg on physical functioning and weight‐ and health‐related quality of life in adults with overweight or obesity: Patient‐reported outcomes from the STEP 1–4 trials
par: Domenica Rubino, et autres
Publié: (2024)

Technology‐delivered personalized nutrition intervention on dietary outcomes among adults with overweight and obesity: A systematic review, meta‐analysis, and meta‐regression
par: Ying Lau, et autres
Publié: (2024)

A meta‐analysis of eHealth interventions to promote physical activity in young, middle‐aged, and late middle‐aged adults with obesity or overweight
par: Seungmin Lee, et autres
Publié: (2025)

Psychological well‐being and the reversal of childhood overweight and obesity in the UK : a longitudinal national cohort study
par: I Gusti Ngurah Edi Putra, et autres
Publié: (2024)

Effects of traditional Chinese medicines on weight management among adults with overweight or obesity: A systematic review and network meta‐analysis
par: Meifang Chen, et autres
Publié: (2024)

Impact of eligibility for diabetes remission on response to intensive lifestyle intervention in overweight and obese people with type 2 diabetes: The Look AHEAD trial
par: Joanna Y. Gong, et autres
Publié: (2025)

Neurological‐related proteomic profiling in plasma of children with metabolic healthy and unhealthy overweight/obesity
par: Marcos Olvera‐Rojas, et autres
Publié: (2024)

Impact of COVID‐19 pandemic on sleep parameters and characteristics in individuals living with overweight and obesity
par: Stephen A. Glazer, et autres
Publié: (2024)

Phase I study of the oral GLP ‐1 receptor agonist DA ‐ 302168S : Safety, pharmacokinetics, and pharmacodynamics in healthy and overweight/obese adults
par: Liang Zheng, et autres
Publié: (2025)

Assessing the effects of naltrexone‐bupropion on hepatic steatosis and fibrosis in patients with T2DM and overweight or obesity: Insights from a placebo‐controlled trial
par: Alina N. Saidi, et autres
Publié: (2025)